» Articles » PMID: 34013060

Factors Predicting Major Complications, Mortality, and Recovery in Percutaneous Endoscopic Gastrostomy

Overview
Journal JGH Open
Specialty Gastroenterology
Date 2021 May 20
PMID 34013060
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aim: Percutaneous endoscopic gastrostomy (PEG) has been used in patients with dysphagia and inadequate food intake via an oral route. Despite being a procedure with a high success rate, complications and death have been reported. The aim was to identify the factors related to major complications and mortality, as well as PEG removal prognostic factors due to improvement of their general condition.

Methods: Patient characteristics, comorbidities, laboratory data, concomitant medication, sedation, and indication for PEG placement were collected. Major complications, mortality, and PEG removal factors were assessed.

Results: A total of 388 patients were enrolled. There were 15 (3.9%) cases of major complications, with major bleeding being the most frequent in 6 (1.5%) patients. Corticosteroids were the independent variable associated with major complications (odds ratio [OR] 5.85; 95% confidence interval [CI] 1.71-20;  = <0.01). Advanced cancer (hazard ratio [HR] 0.5; 95% CI 0.3-1;  = 0.05), albumin (HR 0.6; 95% CI 0.4-0.9;  = <0.01), and C-reactive protein (CRP) (HR 1.1; CI 1-1.2;  = 0.01) were considered risk factors for mortality. Previous pneumonia (HR 0.4; CI 0.2-0.9;  = 0.02) was a factor for permanent use of a PEG; however, oncological indication (HR 8.2; CI 3.2-21;  = <0.01) was factors for PEG withdrawal.

Conclusions: Chronic corticosteroid users potentially present with major complications. Low albumin levels and elevated CRP were associated with death. Previous aspiration pneumonia was a factor associated with permanent use of PEG; however, patients with oncological indication were the most benefited.

Citing Articles

Percutaneous Endoscopic Gastrostomy in the 21st Century-An Overview of 1415 Consecutive Dysphagic Adult Patients.

Mendes I, Vara-Luiz F, Palma C, Nunes G, Lima M, Oliveira C Nutrients. 2025; 17(5).

PMID: 40077616 PMC: 11902068. DOI: 10.3390/nu17050747.


Association between the C-reactive protein/albumin ratio and mortality in older Japanese patients with dysphagia.

Guo C, Zheng P, Chen S, Wei L, Fu X, Fu Y Front Nutr. 2024; 11:1370763.

PMID: 38993239 PMC: 11236619. DOI: 10.3389/fnut.2024.1370763.


Time trends and outcomes of gastrostomy placement in a Swedish national cohort over two decades.

Skogar M, Sundbom M World J Gastroenterol. 2024; 30(10):1358-1367.

PMID: 38596497 PMC: 11000080. DOI: 10.3748/wjg.v30.i10.1358.


Factors Associated With Short-Term Complications After Percutaneous Endoscopic Gastrostomy Tube Insertion: A Retrospective Cohort Study.

Shehata M, Al Hosani I, Ahmed I, Abu Alkas H, Khaddam O, Aljanahi A Cureus. 2024; 16(3):e55741.

PMID: 38463403 PMC: 10920060. DOI: 10.7759/cureus.55741.


Preprocedural control of nutritional status score and prediction of early death after percutaneous endoscopic gastrostomy.

Yoshida Y, Maetani I, Shigoka H, Matsuda T JGH Open. 2023; 7(7):504-508.

PMID: 37496809 PMC: 10366492. DOI: 10.1002/jgh3.12941.


References
1.
Friedenberg F, Jensen G, Gujral N, Braitman L, Levine G . Serum albumin is predictive of 30-day survival after percutaneous endoscopic gastrostomy. JPEN J Parenter Enteral Nutr. 1997; 21(2):72-4. DOI: 10.1177/014860719702100272. View

2.
Pih G, Na H, Ahn J, Jung K, Kim D, Lee J . Risk factors for complications and mortality of percutaneous endoscopic gastrostomy insertion. BMC Gastroenterol. 2018; 18(1):101. PMC: 6025834. DOI: 10.1186/s12876-018-0825-8. View

3.
Peveling-Oberhag J, Osman I, Walter D, Filmann N, Stratmann K, Hausmann J . Risk factors for early and late procedure-related adverse events in percutaneous endoscopic gastrostomy: A single center, retrospective study. J Gastroenterol Hepatol. 2018; 34(2):404-409. DOI: 10.1111/jgh.14407. View

4.
Richards D, Tanikella R, Arora G, Guha S, Dekovich A . Percutaneous endoscopic gastrostomy in cancer patients: predictors of 30-day complications, 30-day mortality, and overall mortality. Dig Dis Sci. 2012; 58(3):768-76. DOI: 10.1007/s10620-012-2397-8. View

5.
Suzuki Y, Tamez S, Murakami A, Taira A, Mizuhara A, Horiuchi A . Survival of geriatric patients after percutaneous endoscopic gastrostomy in Japan. World J Gastroenterol. 2010; 16(40):5084-91. PMC: 2965286. DOI: 10.3748/wjg.v16.i40.5084. View